Email updates

Keep up to date with the latest news and content from Arthritis Research & Therapy and BioMed Central.

Correction

Correction: Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab

Xenofon Baraliakos1, Joachim Listing2, Jan Brandt1, Angela Zink2, Rieke Alten3, Gerd Burmester4, Erika Gromnica-Ihle5, Herbert Kellner6, Matthias Schneider7, Helmut Sörensen8, Hennig Zeidler9, Martin Rudwaleit10, Joachim Sieper10 and Juergen Braun1*

Author affiliations

1 Rheumazentrum Ruhrgebiet, Herne, Ruhr University Bochum, Germany

2 German Rheumatism Research Center, Berlin, Germany

3 Schlosspark Clinic, Berlin, Germany

4 Charité, University Medicine Berlin, Campus Mitte, Germany

5 Berlin-Buch Hospital, Berlin, Germany

6 Ludwig-Maximilians-University, Munich, Germany

7 Heinrich-Heine-University, Düsseldorf, Germany

8 Private Praxis, Berlin, Germany

9 Medical University of Hannover, Hanover, Germany

10 Charité, Medical University of Berlin, Campus Benjamin Franklin, Department of Rheumatology, Germany

For all author emails, please log on.

Citation and License

Arthritis Research & Therapy 2005, 7:113  doi:10.1186/ar1750

Published: 23 March 2005

First paragraph (this article has no abstract)

After publication of this work [1], we noted that we inadvertently failed to include the complete list of all coauthors. The full list of authors has now been added and the Authors' contributions and Competing interests section modified accordingly.